NASDAQ: TEM

Tempus AI (TEM) Stock Analysis & Forecast

Nov 13 close

$71.60−4.29 (−5.7%)

Gekko Brief

Nov 9 close

Tempus AI closed at $84.44 on 9 November 2026, +11% on the day. The price sits above both the 50-day ($71.73) and 200-day ($57.23) moving averages, inside a 52-week range of $40.77 to $89.09. The GekkoIndex reads 52.7, in the Neutral zone, down 0.9 points over five sessions. Gekko Fair Value is $75.95, so the price is 11.2% above it.

The next earnings report is due on 23 February 2027, 100 days away (after close). Over the last 8 reports the company beat the earnings estimate 7 times, with an average move of 7% across the report. Over the last 30 days there were 7 unusual options signals.

14 firms rate the stock: 8 buy, 6 hold and 0 sell, with a consensus target of $82.89. A typical daily move is about 8.2%, and a typical 20-day move about 14.9%. On the swing-trade checklist, 2 items read supportive and 2 read as a headwind (fair value, smart money).

A plain summary of the figures as of the Nov 9, 2026 close.

Tempus AI price vs fair value

$79.53$71.60Nov ’25May ’26Nov ’26
Close $71.60200-day averageGekko Fair Value $79.53

Tempus AI quick facts

Market cap
$12.69B
P/E ratio
—
Forward P/E
—
EPS, TTM
−$1.06
Revenue, TTM
$1.51B
Profit margin
-12.5%
Dividend yield
—
Beta
3.61
Volume
5.29M avg 6.34M
1-year return
+0.7%
Typical daily move
±10.5%
Typical 20-day move
±14.9%
50-day average
$72.84
200-day average
$57.45
Next earnings
Feb 23 after close
Shares outstanding
177.4M
52-week range
$40.77$89.09

Tempus AI swing-trade checklist

Tempus AI scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

3 supportive1 mixed1 headwind

  • Trendmixed

    Averages disagree

    Close $71.60 sits between the 50-day ($72.84) and 200-day ($57.45) averages, or the averages disagree.

    See the chart
  • GekkoIndexsupportive

    60.5, Accumulation

    Reading 60.5 is in the Accumulation zone.

    See the GekkoIndex
  • Fair valuesupportive

    10.0% below

    Price is 10% below Gekko Fair Value (more than 5% below).

    See fair value
  • Smart moneyheadwind

    Leans bearish

    Last 30 days: 6 unusual options signals.

    See smart money
  • Earnings risksupportive

    Reports in 100 days

    Next report Feb 23, 2027, 100 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalityno data

    No data

    Not enough years of history for a seasonal read.

A description of current data, not a recommendation. How this page works

Tempus AI stock chart and price history

Tempus AI closed at $71.60 on Nov 13, 2026, +0.7% over the past year, inside a 52-week range of $40.77 to $89.09.

Close50-day average200-day averageVolume
Tempus AI share price, past year, with 50-day and 200-day moving averages and volume$40$50$60$80DecJan 2026FebMarAprMayJunJulAugSepOctNov71.60

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
+0.7%
3 months
+38.7%
6 months
+63.0%
1 year
+0.7%
The full TEM chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open TEM in Gekko

Follow Tempus AI through every session

Put TEM on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track TEM in GekkoFree for 7 days. No credit card required.

About Tempus AI

Tempus AI builds technology for healthcare providers, connecting clinicians to laboratory diagnostics, data analytics and a broad library of multimodal patient information. Its platform links a doctor's desktop directly to testing capabilities, and the company is recognized for tools such as Hub, an application that guides physicians through next-generation sequencing tests from start to finish, and Lens, used for precision research in the life sciences.

The company's offerings extend across diagnostics, including sequencing, PCR profiling and pathology testing, along with specialized assays for tumor and blood cancer analysis, inherited conditions, and psychiatric pharmacogenomics. It also licenses de-identified clinical and molecular data through a product called Insights, models tumor behavior through Organoids, matches patients to clinical trials, and runs an AI platform called Next alongside an algorithm-based diagnostics tool named Algos. Tempus AI works with pharmaceutical and biotechnology partners such as AstraZeneca, Pathos AI, GlaxoSmithKline, Merck and Recursion Pharmaceuticals, and it collaborates with Blood Cancer United on a pediatric leukemia registry.

Founded in 2015 under the name Tempus Labs before adopting its current name in 2023, the company is based in Chicago, Illinois. Its shares are listed on the NASDAQ under the ticker TEM.

Listed
NASDAQ
Sector
Technology services
Industry
Packaged software
Website
tempus.com

Tempus AI GekkoIndex: the smart money zone

Tempus AI’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 60.5, in the Accumulation zone, up 3.4 points over five sessions.

010060.5Accumulation

Up 3.4 points over five sessions, from the Neutral zone.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying38+2.8%+11.5%+19.7%+32.9%
Accumulation (current zone)203+3.9%+8.0%+15.3%+15.5%
Neutral313+0.4%+0.1%+0.4%+5.5%
Distribution42−0.3%−2.1%−10.0%−15.3%
Selling1Too few readings yet

Average TEM share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.

Accumulation zone: Institutional interest building. About the five zones →

See every daily GekkoIndex reading plotted over the TEM price, zone by zone.Track TEM in Gekko

Is Tempus AI stock overvalued? Gekko Fair Value

Tempus AI trades 10.0% below Gekko Fair Value of $79.53, so the shares are undervalued on Gekko’s estimate.

Gekko’s own estimate of what Tempus AI shares are worth, recalculated every trading day.

$79.53

Gekko Fair Value, Nov 14, 2026

10.0% Undervalued

At the end of Aug 2026 the price was 4.5% above the estimate.

Gekko Fair ValueShare price, month end
$80$72Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open TEM in Gekko

Tempus AI insider and Congress trading

No open-market insider purchases were filed for Tempus AI, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for TEM in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every TEM insider filing, plotted on the chart in Gekko.Open TEM in Gekko

Congress trades last 90 days

No trades in TEM were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for TEM, plotted on the chart in Gekko.Open TEM in Gekko

Buybacks

Tempus AI has been buying back its own shares.

Bought back, quarter ended Dec 31, 2025
$3.04M
As a share of market cap
0.02%

From company filings.

Unusual options activity last 30 days

6signals, 43% of the flagged premium in calls.

Latest: Bearish flow on Nov 7, $316K in unusual premium.

Hedge funds and billionaires quarter ended Sep 30

1of the funds Gekko tracks holds TEM.

0added1opened0trimmed1sold out
Every signal with its contract, strike and premium, and which funds are on each side.Unlock in Gekko

Tempus AI earnings: next date and track record

Tempus AI reports on Feb 23, 2027, after the close (100 days away), and beat the EPS estimate in 7 of its last 8 reports.

7 of 8reports beat the EPS estimate
±7%average move across the report
4 of 8reports followed by a gain

Share-price move across each report

−13.2%Feb ’25+8.7%May ’25+3.5%Aug ’25−7.3%Nov ’25−6.2%Feb ’26−4.1%May ’26+5.6%Jul ’26+7.7%Nov ’26

Last earnings call, Nov 2, 2026 AI summary

What they said
Tempus Q3 2026 revenue reached $412M, up 23% YoY. Diagnostics revenue grew 20% to $304M, with oncology up 28% on 32% volume growth. Data and Apps revenue surged 33% to $108M. Adjusted EBITDA turned positive at $25.6M. Key wins include a $193M BMS/Pathos collaboration, Moderna/Merck MRD partnership, and pending Personalis acquisition clearance. Cash position stands at $854M.
Guidance
Management expects $193M in additional Data and Apps revenue over approximately 5 years from BMS and Pathos agreements. Personalis shareholder vote scheduled November 30, with anticipated synergies accelerating MRD commercial adoption in a $20B+ market.
ReportedEPSSurpriseRevenueSurpriseMove
Nov 2, 2026$0.07
est −$0.09
+174.7%$411.5M
est $409.4M
+0.5%+7.7%
Jul 30, 2026−$0.04
est −$0.14
+72.0%$382.5M
est $379.7M
+0.7%+5.6%
May 5, 2026−$0.13
est −$0.21
+38.1%$348.1M
est $345.4M
+0.8%−4.1%
Feb 24, 2026−$0.04
est −$0.04
+8.7%$367.2M
est $362.6M
+1.3%−6.2%
Nov 4, 2025−$0.11
est −$0.17
+36.2%$334.2M
est $328.7M
+1.7%−7.3%
Aug 8, 2025−$0.22
est −$0.23
+4.3%$314.6M
est $297.7M
+5.7%+3.5%
May 6, 2025−$0.24
est −$0.26
+7.7%$255.7M
est $248.1M
+3.1%+8.7%
Feb 24, 2025−$0.18
est −$0.15
−20.0%$200.7M
est $248.8M
−19.4%−13.2%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Tempus AI stock forecast and analyst price targets

Analysts’ average 12-month price target for Tempus AI is $89.56, +25.1% from the last close, from 14 firms rating the stock in the last 90 days.

$89.56consensus 12-month target, +25.1% from the last close
Low $67High $120
Buy8
Hold6
Sell0

Each firm’s latest rating in the last 90 days: 14 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Nov 3Canaccord GenuityBuy, reiterated$95+32.7%
Nov 3H.C. WainwrightBuy, reiterated$85+18.7%
Nov 3Robert W. BairdBuy, maintained$92+28.5%
Nov 3Mizuho SecuritiesBuy, maintained$120+67.6%
Nov 2JefferiesHold, upgraded$70−2.2%
+15.3%average 20-day move after past Accumulation readings
±10.5%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Tempus AI market cap and key statistics

Tempus AI’s market cap is $12.69B and revenue of $1.51B over the last twelve months.

Valuation

Market cap
$12.69B
EPS, TTM
−$1.06
Gekko Fair Value
$79.53

Trading

Volume
5.29M
Avg volume, 20 days
6.34M
52-week high
$89.09
52-week low
$40.77
Shares outstanding
177.4M

Financials

Revenue, TTM
$1.51B
Profit margin
-12.5%
Return on equity
-37.6%
Quarterly earnings growth, YoY
0.0%

Risk and income

Beta
3.61
Typical daily move
±10.5%
Typical 20-day move
±14.9%

Tempus AI peers

Tempus AI’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
MSFTMicrosoft+0.8%Neutral10.6% above
PLTRPalantir Technologies−2.2%Accumulation8.2% below
ORCLOracle−1.7%Neutral27.9% below
PANWPalo Alto Networks−2.5%Accumulation0.6% above
CRWDCrowdStrike−4.0%Accumulation0.9% above
CRMSalesforce−1.0%Accumulation12.1% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Packaged software

Tempus AI stock FAQ

What is Tempus AI’s market cap?

Tempus AI’s market cap is $12.69B at the Nov 13, 2026 close of $71.60, with 177.4M shares outstanding.

What is the Tempus AI stock forecast?

The consensus analyst 12-month price target for Tempus AI is $89.56, +25.1% from the last close. Of the 14 firms that rated the stock in the last 90 days, 8 rate it a buy, 6 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.

Is Tempus AI stock overvalued or undervalued?

On Gekko’s estimate Tempus AI is undervalued: the Nov 13, 2026 close of $71.60 is 10.0% below Gekko Fair Value of $79.53. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Tempus AI report earnings next?

Tempus AI is expected to report on Feb 23, 2027, after the market closes (100 days away). Analysts expect earnings of $0.06 per share on revenue of $459.2M. Tempus AI beat the earnings estimate in 7 of its last 8 reports, moving 7% on average across the report.

What is Tempus AI’s 52-week high and low?

Tempus AI’s 52-week high is $89.09 and its 52-week low is $40.77; it closed at $71.60 on Nov 13, 2026, +0.7% over the past year. Over the last five years the shares peaked at $104.32 on Oct 9, 2025.

Is Tempus AI stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and earnings risk), 1 as mixed (trend) and 1 as a headwind (smart money). The checklist is a description of current data, not a recommendation.

Is there unusual options activity in Tempus AI?

Gekko flagged 6 unusual options signals in Tempus AI over the last 30 days, with $2.39M of flagged premium in calls and $3.16M in puts. The latest, bearish flow, was on Nov 7, 2026 with $316K in unusual premium. The signal-by-signal table is in Gekko.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Tempus AI the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.